Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Unterrainer

Showing results (371-380 of 459) with videos related to

Pageof 46
Sort By:
Annals of Hematology|October 20, 2023
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
EJNMMI Research|November 19, 2017
TSPO imaging using the novel PET ligand [<sup>18</sup>F]GE-180: quantification approaches in patients with multiple sclerosisLena Vomacka, Nathalie Lisa Albert, Simon Lindner, et al.
Epilepsy & Behavior : E&B|February 23, 2007
Assessment of cognitive functions before and after stereotactic interstitial radiosurgery of hypothalamic hamartomas in patients with gelastic seizuresA Quiske, J Unterrainer, K Wagner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2021
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directionsChukwuka Eze, Nina-Sophie Schmidt-Hegemann, Lino Morris Sawicki, et al.
Frontiers in Oncology|May 17, 2021
TERT-Promoter Mutational Status in Glioblastoma - Is There an Association With Amino Acid Uptake on Dynamic <sup>18</sup>F-FET PET?Marcus Unterrainer, Viktoria Ruf, Katharina von Rohr, et al.
Cytotherapy|April 13, 2023
Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Radiation Oncology (London, England)|December 2, 2022
<sup>18</sup>F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapyTun Wiltgen, Daniel F Fleischmann, Lena Kaiser, et al.
Journal of Personality Assessment|January 10, 2020
A Bifactor Model of Personality OrganizationSusanne Hörz-Sagstetter, Jana Volkert, Michael Rentrop, et al.
Frontiers in Psychiatry|October 26, 2020
The Influence of an Attachment-Related Stimulus on Oxytocin Reactivity in Poly-Drug Users Undergoing Maintenance Therapy Compared to Healthy ControlsJürgen Fuchshuber, Jasmin Tatzer, Michaela Hiebler-Ragger, et al.
Pageof 46

Showing results (371-380 of 459) with videos related to

Sort By:
Pageof 46
Annals of Hematology|October 20, 2023
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
EJNMMI Research|November 19, 2017
TSPO imaging using the novel PET ligand [<sup>18</sup>F]GE-180: quantification approaches in patients with multiple sclerosisLena Vomacka, Nathalie Lisa Albert, Simon Lindner, et al.
Epilepsy & Behavior : E&B|February 23, 2007
Assessment of cognitive functions before and after stereotactic interstitial radiosurgery of hypothalamic hamartomas in patients with gelastic seizuresA Quiske, J Unterrainer, K Wagner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2021
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directionsChukwuka Eze, Nina-Sophie Schmidt-Hegemann, Lino Morris Sawicki, et al.
Frontiers in Oncology|May 17, 2021
TERT-Promoter Mutational Status in Glioblastoma - Is There an Association With Amino Acid Uptake on Dynamic <sup>18</sup>F-FET PET?Marcus Unterrainer, Viktoria Ruf, Katharina von Rohr, et al.
Cytotherapy|April 13, 2023
Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapyMichael Winkelmann, Viktoria Blumenberg, Kai Rejeski, et al.
Radiation Oncology (London, England)|December 2, 2022
<sup>18</sup>F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapyTun Wiltgen, Daniel F Fleischmann, Lena Kaiser, et al.
Journal of Personality Assessment|January 10, 2020
A Bifactor Model of Personality OrganizationSusanne Hörz-Sagstetter, Jana Volkert, Michael Rentrop, et al.
Frontiers in Psychiatry|October 26, 2020
The Influence of an Attachment-Related Stimulus on Oxytocin Reactivity in Poly-Drug Users Undergoing Maintenance Therapy Compared to Healthy ControlsJürgen Fuchshuber, Jasmin Tatzer, Michaela Hiebler-Ragger, et al.
Pageof 46